DIPGF yields 6.10% · JNJ yields 2.13%● Live data
📍 DIPGF pulled ahead of the other in Year 1
Combined, DIPGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DIPGF + JNJ for your $10,000?
Datang International Power Generation Co., Ltd., together with its subsidiaries, engages in power generation and power plant development activities in the People's Republic of China. The company operates through Power and Heat Generation, Coal, and Other segments. It generates electricity through various sources, such as coal-fired, thermal, hydro, wind, nuclear, and solar. As of December 31, 2021, the company managed an installed capacity of 68,770.03 MW. It also engages in heat supply; the import of power related fuel; coal mining and trading; silicon and aluminum smelting; production and sale of alumina; cargo shipping; sale of coal ash and integrated application of solid waste; power plant construction and operation; repair and testing of power equipment; research and development activities; and provision of power related technical services. The company was formerly known as Beijing Datang Power Generation Co., Ltd and changed its name to Datang International Power Generation Co., Ltd. in April 2004. The company was incorporated in 1994 and is based in Beijing, the People's Republic of China. Datang International Power Generation Co., Ltd. is a subsidiary of China Datang Corporation Limited.
Full DIPGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.